Pure Bioscience's total assets for Q4 2024 were $818.00K, a decrease of -11.09% from the previous quarter. PURE total liabilities were $3.68M for the fiscal quarter, a 452.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.